Metformin in semi-solid matrices: a new approach for improved bioavailability and extension of its anti-diabetic action
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: YOUNES, Husam (Qatar University, Pharmaceutics & Polymeric Drug Delivery Research Lab, Doha, Qatar)
- Co-author(s): Abu Helwa, Ahmed (Qatar University, Doha, Qatar)
Background: Metformin hydrochloride (MH), a commonly prescribed drug for type-2 diabetes has a short and variable biological half-life, thus, needs repeated administration of high doses. The drug also possesses very low bioavailability due to the specificity of its absorption site in the GIT. The purpose of this work is to formulate and evaluate.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.